Abstract:The α,β-unsaturated-enone contained natural products have been reported showing NF-κB inhibition effect. It is well known that NF-κB inhibitors can also be used to inhibit osteoclastogenesis. In a continual discovery new agents for anti-osteoclastogenesis, 8 different type compounds with α,β-unsaturated-enone fragments from our in-house library were evaluated for NF-κB inhibition and anti-osteoclastogenesis. Experimental results indicated five compounds exhibited inhibition of NF-κB signal pathway. Among them, one compound ((E)-2-(4-fluorobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, 6a) simultaneously inhibits both osteoclastogenesis and NF-κB signal pathway. Furthermore, 12 compounds with similar scaffold with 6a were tested for anti-osteoclastogenesis. As a result, 9 compounds inhibited both NF-κB and osteoclastogenesis. Among them, compound 6b is the most potent inhibitor against NF-κB (IC50 = 2.09 μM) and osteoclast differentiation (IC50 = 0.86 μM). Further studies show that compound 6b blocks the phosphorylation of both p65 and IκBα, and suppresses NF-κB targeted gene expression without interfering MAPKs and PI3K/Akt signal transduction pathways. This study demonstrates that we can identify promising synthesized compounds with new scaffolds as therapeutic solutions against osteoclastogenesis inspired by the privileged fragment derived from natural leads.

Discovery of Ingenane and Jatrophane Diterpenoids from Euphorbia Esula As Inhibitors of RANKL-induced Osteoclastogenesis.

Discovery of Diverse Diterpenoid Scaffolds from Euphorbia Antiquorum and Their Activity Against RANKL-induced Osteoclastogenesis.

Triterpenoids from Euphorbia Pulcherrima with Inhibitory Effects on Osteoclastogenesis

Identification and Structural Modification of Ent-Rosane Diterpenoids from Euphorbia Milii Inhibiting RANKL-induced Osteoclastogenesis

Euphoesulatin A Prevents Osteoclast Differentiation and Bone Loss Via Inhibiting RANKL-induced ROS Production and NF-κB and MAPK Signal Pathways.

Diverse Diterpenoids and Sesquiterpenoids from Siegesbeckia Pubescens and Their Activity Against RANKL-induced Osteoclastogenesis

Euphoresulanes A-M, structurally diverse jatrophane diterpenoids from <i>Euphorbia esula</i>

Diterpenoids from the Whole Plants of Ajuga Nipponensis and Their Inhibition of RANKL‐Induced Osteoclastogenesis

Diterpenes inhibiting NO production from Euphorbia helioscopia.

Jatrophane Diterpenoids from Euphorbia Peplus As Multidrug Resistance Modulators with Inhibitory Effects on the ATR-Chk-1 Pathway.

Discovery of New Inhibitors Against Both NF-κB and Osteoclastogenesis from In-House Library with Α, Β-Unsaturated-enone Fragment.

Pepluane and Paraliane Diterpenoids from Euphorbia Peplus with Potential Anti-inflammatory Activity

Lanostane Triterpenes Isolated from Antrodia Heteromorpha and Their Inhibitory Effects on Rankl-Induced Osteoclastogenesis

Diterpenoids with anti-inflammatory activity from Euphorbia wallichii

New Macrocyclic Diterpenoids from Euphorbia Esula

Diverse Sesquiterpenoids and Polyacetylenes from <i>Atractylodes lancea</i> and Their Anti-Osteoclastogenesis Activity

Ingenane and jatrophane-type diterpenoids from Euphorbia kansui with multidrug resistance reversal activity

Lathyrane and Jatrophane Diterpenoids from Euphorbia helioscopia Evaluated for Cytotoxicity against a Paclitaxel-Resistant A549 Human Lung Cancer Cell Line.

Novel Jatrophane Diterpenoids from Euphorbia esul a Promotes Lipid Clearance by Transcriptional Regulation of PCSK9

Novel Jatrophane Diterpenoids from Euphorbia Esula Promotes Lipid Clearance by Transcriptional Regulation of PCSK9

Structural Elucidation of Three 9,11-Seco Tetracyclic Triterpenoids Enables the Structural Revision of Euphorol J